LISI GP HOLD (00526) Issues Profit Warning, Expects Interim Net Profit to Fall to Not Less Than RMB34 Million
LISI GP HOLD (00526) announced that the Group is expected to record a net profit of not less than RMB34 million for the six months ended September 30, 2026, compared with a net profit of approximately RMB44.6 million in the same period last year.
LISI GP HOLD (00526) announced that the group is expected to record a net profit of not less than RMB34 million for the six months ended September 30, 2026, compared with a net profit of approximately RMB44.6 million in the same period last year.
The board believes that the decrease in profit is mainly attributable to the following reasons: during the period, affected by continued tariffs and geopolitical factors, a decline in exports led to lower revenue; in addition, amid the continued downturn in the real estate market, contracted projects also decreased; and during the period, an increase in valuation losses arising from the revaluation of investment properties; partly offset by a decrease in impairment losses on financial assets and contract assets during the period.
Related Articles

YUM CHINA (09987) repurchased 35,600 shares on November 16 for approximately HK$14.1806 million.

GLOBAL BIO-CHEM (00809) intends to sell all equity interests in Changchun Dacheng Bio-Technology through public tender.

NIKE, Inc. Class B (NKE.US) lays out a clear growth path for the next five years: targeting US$5 billion in incremental revenue by fiscal 2031.
YUM CHINA (09987) repurchased 35,600 shares on November 16 for approximately HK$14.1806 million.

GLOBAL BIO-CHEM (00809) intends to sell all equity interests in Changchun Dacheng Bio-Technology through public tender.

NIKE, Inc. Class B (NKE.US) lays out a clear growth path for the next five years: targeting US$5 billion in incremental revenue by fiscal 2031.






